Westfield Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Westfield Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-406,716	Closed	-$45.9M	–	312
2015 Q4	$45.9M	Buy	+406,716	New	+$44.8M	0.31%	106
2014 Q3	–	Sell	-1,659,070	Closed	-$29.4M	–	344
2014 Q2	$29.4M	Buy	1,659,070 +520,540	+46%	+$8.38M	0.18%	164
2014 Q1	$22.8M	Buy	+1,138,530	New	+$22.1M	0.14%	200

Other funds holding ANAC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Westfield Capital Management's ANAC Position: Q1 2016 in Review

Westfield Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2016, closing a stake of 406,716 shares — an estimated $45.9M sold.

Westfield Capital Management first reported a position in ANAC in Q1 2014 and held it in 3 quarters. The position peaked at $45.9M in Q4 2015. 199 funds tracked by Wall St. Rank hold ANAC as of Q1 2016.

Westfield Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2016 after selling out during the quarter.
Westfield Capital Management sold 406,716 ANACOR PHARMACEUTICALS INC COM shares in Q1 2016, an estimated $45.9M.
Westfield Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 3 quarters.
Westfield Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $45.9M in Q4 2015.
199 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2016.

Based on Westfield Capital Management's 13F filing for Q1 2016, filed 13 May 2016.